Abstracts tagged "DXA and osteoporosis"

Abstract Number: 2316 • 2018 ACR/ARHP Annual Meeting
Errors and Discrepancies in DXA Scans in Imaging Centers in Ecuador
Genessis Maldonado¹, Maria Jose Intriago¹, Maria Larroude², Gabriel Aguilar³, Mario Moreno⁴, Jose Gonzalez⁵, Sara Vargas⁵, Claudia Vera⁶, Roberto Guerrero¹, Karla Ríos¹ and Carlos Rios¹, ¹Universidad Espiritu Santo, Guayaquil, Ecuador, ²Centro Diagnostico Rossi, CABA, Argentina, ³Centro de Diagnostico Rossi, Buenos Aires, Argentina, ⁴Rheumatology, Hospital Luis Vernaza, Rheumatology Service, Guayaquil, Ecuador, ⁵Ecuadorian Rheumatology Society, Guayaquil, Ecuador, ⁶Universidad Catolica Santiago de Guayaquil, Guayaquil, Ecuador
Background/Purpose: Dual-energy X-ray absorptiometry (DXA) is recognized as the gold standard for measuring bone mineral density (BMD) with acceptable errors, good precision and reproducibility. However,…
Abstract Number: 2023 • 2016 ACR/ARHP Annual Meeting
Patient Barriers to Osteoporosis Screening in a Medical Clinic: Why Underserved Patients Who Follow Recommendations for Colonoscopy and Mammography Fail to Get Their DXA Scans
Suzana John¹, Sonam Kiwalkar², Hamdy Mohamed Abdelaziz Ahmed¹ and Walter Polashenski³, ¹Internal Medicine, Rochester General Hospital, Rochester, NY, ²internal medicine, Rochester general hospital, Rochester, NY, ³Internal medicine, Rochester general hospital, rochester, NY
Background/Purpose: Osteoporosis is a silent disease until it is complicated by fractures. Fractures are common; they place an enormous medical and personal burden on the elderly and take a major economic toll…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].